======= FLG2 ======= == Gene Information == * **Official Symbol**: FLG2 * **Official Name**: filaggrin family member 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=388698|388698]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5D862|Q5D862]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FLG2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FLG2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616284|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |S 100| |keratohyalin granule| |structural constituent of epidermis| |transition metal ion binding| |establishment of skin barrier| |regulation of water loss via skin| |epidermis morphogenesis| |tertiary granule lumen| |cornified envelope| |multicellular organismal water homeostasis| |water homeostasis| |multicellular organismal homeostasis| |skin development| |epidermis development| |morphogenesis of an epithelium| |neutrophil degranulation| |neutrophil activation involved in immune response| |regulation of body fluid levels| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |tissue morphogenesis| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |calcium ion binding| |leukocyte mediated immunity| |exocytosis| |leukocyte activation| |cell adhesion| |biological adhesion| |secretion by cell| |export from cell| |cell activation| |immune effector process| |chemical homeostasis| |epithelium development| |secretion| |homeostatic process| |tissue development| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-2.17| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-1.91| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|-1.78| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|1.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14297 * **Expression level (log2 read counts)**: 1.0 {{:chemogenomics:nalm6 dist.png?nolink |}}